jCell intravitreal retinal progenitor cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for jCell intravitreal retinal progenitor cell therapy, covering 2022-01-21 to 2022-01-21. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa [Phase 2]